Market Tracker

10/20 6:05pm ET

Alkermes Plc (NASDAQ:ALKS)

During the Trading Day
43.17 +0.09 / +0.21%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
43.16 -0.006 / -0.01%
 
Volume: 200.00

Today’s Trading

Previous close43.08
Today’s open42.88
Day’s range42.83 - 43.94
Volume596,323
Average volume (3 months)862,688
Market cap$6.3B
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.69%
Earnings growth (next 5 years)+20.24%
Revenue growth (last year)+47.59%
P/E ratio359.8
Price/Sales5.42
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.02-0.01%
IDXXIDEXX Laboratories I...+1.23+1.03%
UTHRUnited Therapeutics ...+1.80+1.44%
PBYIPuma Biotechnology I...+2.70+1.21%
Data as of 4:02pm ET, 10/20/2014

Financials

Next reporting dateOctober 31, 2014
EPS forecast (this quarter)$0.03
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts